analyst
VK
NASDAQ · VKTX
Viking Therapeutics, Inc.
Healthcare · Biotechnology
$29.28
Down-$0.90 (-3.07%)
Updated Oct 6, 2026, 9:41 PM
SID Score
4.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.21B
- P/E ratio
- -17.61
- Dividend yield
- 0.00%
- 52-week range
- $27.16 – $43.10
- Volume
- 6.28M
- Avg. volume
- 4.44M
Price performance · VKTX
VKTX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
VKTX closed at $29.28 after 20 trading sessions, down 13.06% for the selected period.
- Last close
- $29.28
- Period change
- -13.06%
- Period low
- $28.99
- Period high
- $41.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $30.14 | $30.18 | $28.71 | $29.28 | 6.28M |
| Oct 2, 2026 | $30.85 | $31.09 | $29.90 | $29.94 | 6.37M |
| Oct 1, 2026 | $31.92 | $32.48 | $30.43 | $30.51 | 6.83M |
| Sep 30, 2026 | $31.855 | $33.29 | $31.20 | $32.60 | 7M |
| Sep 29, 2026 | $33.11 | $33.6469 | $31.42 | $31.81 | 8.03M |
| Sep 28, 2026 | $35.00 | $35.1896 | $32.91 | $33.03 | 8.58M |
| Sep 25, 2026 | $37.80 | $39.0451 | $35.10 | $35.56 | 13.58M |
| Sep 24, 2026 | $36.025 | $37.22 | $35.11 | $36.75 | 28.71M |
| Sep 23, 2026 | $41.76 | $43.10 | $37.71 | $41.65 | 15.73M |
| Sep 22, 2026 | $37.00 | $41.7252 | $36.34 | $40.85 | 41.23M |
| Sep 21, 2026 | $29.57 | $30.70 | $28.41 | $30.11 | 5.09M |
| Sep 18, 2026 | $29.57 | $29.68 | $28.40 | $28.99 | 2.67M |
| Sep 17, 2026 | $30.24 | $30.54 | $29.26 | $29.36 | 2.09M |
| Sep 16, 2026 | $30.02 | $30.77 | $28.80 | $29.52 | 3.01M |
| Sep 15, 2026 | $31.21 | $31.25 | $29.70 | $29.95 | 2.81M |
| Sep 14, 2026 | $31.70 | $32.43 | $31.39 | $31.53 | 1.85M |
| Sep 11, 2026 | $32.26 | $33.05 | $31.70 | $31.98 | 2.21M |
| Sep 10, 2026 | $32.50 | $32.65 | $31.87 | $32.13 | 1.72M |
| Sep 9, 2026 | $33.36 | $34.60 | $32.59 | $32.70 | 2.04M |
| Sep 8, 2026 | $34.63 | $34.81 | $33.53 | $33.68 | 1.87M |
Latest VKTX news
The latest Smart Investors Daily articles mentioning VKTX.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

